Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

CVD Risk Prediction Tool Could Guide Statin Therapy

By HospiMedica International staff writers
Posted on 18 Sep 2025

Cardiovascular disease (CVD) remains one of the leading causes of morbidity and mortality, making accurate risk assessment essential for guiding preventive therapy. More...

Existing tools, such as the Pooled Cohort Equations (PCEs), are widely used, but their thresholds for treatment recommendations may not fully capture patient risk. Now, researchers have developed a new predictive model to refine decision-making, particularly around the use of statin therapy for primary prevention.

Researchers at Northwestern Medicine (Chicago, IL, USA) have created the PREVENT (Predicting Risk of cardiovascular disease EVENTs) risk equations, initially developed for the American Heart Association in 2023. These equations aim to more accurately estimate CVD risk compared with prior models. The tool provides updated thresholds for when clinicians should consider prescribing statins, supporting shared decision-making between patients and healthcare providers.

In the latest study, the researchers conducted a cross-sectional analysis of more than 5,200 U.S. adults aged 40 to 75 from the National Health and Nutrition Examination Surveys. Representing 133 million adults, the study showed that 28.1 million were already on statins and 15.2 million were eligible due to existing high-risk conditions. Of the remaining population, PREVENT identified 11.8 million additional individuals who would benefit from statin therapy with a 10-year CVD risk of 5 percent or greater.

The findings, published in JAMA Cardiology, demonstrated that PREVENT not only detects risk more accurately but also identifies a “sweet spot” at 3 to 5 percent 10-year risk, where the greatest benefit from lipid-lowering medication occurs. This could reshape treatment recommendations by ensuring patients most likely to benefit are prioritized, while lower-risk individuals receive more personalized discussions. Future work will focus on improving risk communication strategies to support patient understanding and adherence.

“If a clinician can have a conversation with their patient explaining that there is a certain threshold after which intervention is recommended because the benefit of starting the intervention is greater than any potential harm, this is often a concept patients understand and can help make them more confident in the decision to adhere to their providers’ recommendations,” said Sadiya Khan, MD, MSc, lead author of the study.

Related Links:
Northwestern Medicine


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical Dressing
ALLEVYN Ag+ SURGICAL
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.